Income Statement LANXESS AG

Equities

LXS

DE0005470405

Diversified Chemicals

Market Closed - Xetra Other stock markets 16:35:19 18/02/2026 GMT			5-day change	1st Jan Change
20.00 ^EUR	-1.48%		-6.10%	+13.51%

02-16	LANXESS AG : UBS reiterates its Sell rating	ZD
02-10	Goldman Turns More Optimistic for Chemicals Sector - Recovery Gains Momentum	DP

cfdf0f5b0f58b2.TeKGX0QkV7DBDhIjb-xgEYYLXrM5DYl5aIoFWXhFwwM.CafgbX1jFua1PEBUWb05S-tPPedXYtADIrIoEAgBonoEr_weK3s91rB4YQ

Published financial data: LANXESS AG

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	6.1B	7.56B	8.09B	6.71B	6.37B
Total Revenues	6.1B	7.56B	8.09B	6.71B	6.37B
Cost of Goods Sold, Total	4.55B	5.71B	6.15B	5.45B	5.07B
Gross Profit	1.56B	1.84B	1.94B	1.27B	1.3B
Selling General & Admin Expenses, Total	1.06B	1.27B	1.4B	1.24B	1.18B
R&D Expenses	108M	115M	102M	99M	104M
Other Operating Expenses	13M	-23M	60M	12M	-6M
Other Operating Expenses, Total	1.18B	1.36B	1.56B	1.35B	1.28B
Operating Income	376M	486M	377M	-81M	23M
Interest Expense, Total	-66M	-67M	-75M	-70M	-47M
Interest And Investment Income	900M	12M	7M	10M	6M
Net Interest Expenses	834M	-55M	-68M	-60M	-41M
Income (Loss) On Equity Invest.	-	-	3M	-172M	-133M
Currency Exchange Gains (Loss)	4M	6M	5M	11M	15M
Other Non Operating Income (Expenses)	4M	14M	52M	-32M	19M
EBT, Excl. Unusual Items	1.22B	451M	369M	-334M	-117M
Restructuring Charges	-72M	-39M	-	-22M	-
Merger & Related Restructuring Charges	-	-16M	-11M	-52M	-
Impairment of Goodwill	-	-	-	-406M	-
Gain (Loss) On Sale Of Assets	1M	1M	-3M	2M	1M
Asset Writedown	-2M	-	-17M	-	-
Other Unusual Items	-71M	-94M	-81M	-135M	-81M
EBT, Incl. Unusual Items	1.07B	303M	257M	-947M	-197M
Income Tax Expense	165M	84M	72M	-105M	-21M
Earnings From Continuing Operations	909M	219M	185M	-842M	-176M
Earnings Of Discontinued Operations	-7M	48M	66M	1.29B	-
Net Income to Company	902M	267M	251M	444M	-176M
Minority Interest	-17M	-	-1M	-1M	-1M
Net Income - (IS)	885M	267M	250M	443M	-177M
Net Income to Common Incl Extra Items	885M	267M	250M	443M	-177M
Net Income to Common Excl. Extra Items	892M	219M	184M	-843M	-177M
Per Share Items
Net EPS - Basic	10.22	3.09	2.9	5.13	-2.05
Basic EPS - Continuing Operations	10.3	2.54	2.13	-9.76	-2.05
Basic Weighted Average Shares Outstanding	86.59M	86.35M	86.35M	86.35M	86.35M
Net EPS - Diluted	10.22	3.09	2.9	5.13	-2.05
Diluted EPS - Continuing Operations	10.3	2.54	2.13	-9.76	-2.05
Diluted Weighted Average Shares Outstanding	86.59M	86.35M	86.35M	86.35M	86.35M
Normalized Basic EPS	8.6	3.26	2.66	-2.43	-0.86
Normalized Diluted EPS	8.6	3.26	2.66	-2.43	-0.86
Dividend Per Share	1	1.05	1.05	0.1	0.1
Payout Ratio	9.27	32.21	36.4	20.54	-5.08
American Depositary Receipts Ratio (ADR)	0.2	0.2	0.2	0.2	0.2
Supplemental Items
EBITDA	784M	934M	855M	420M	521M
EBITA	465M	598M	533M	87M	185M
EBIT	376M	486M	377M	-81M	23M
EBITDAR	791M	943M	865M	431M	534M
Effective Tax Rate - (Ratio)	15.36	27.72	28.02	11.09	10.66
Total Current Taxes	117M	25M	20M	18M	40M
Total Deferred Taxes	48M	59M	52M	-123M	-61M
Normalized Net Income	744M	282M	230M	-210M	-74.12M
Interest Capitalized	3M	3M	2M	1M	-
Interest on Long-Term Debt	7M	6M	4M	6M	6M
Non-Cash Pension Expense	22M	16M	19M	20M	20M
Supplemental Operating Expense Items
Marketing Expenses	469M	536M	593M	583M	583M
Selling and Marketing Expenses	773M	951M	1.06B	933M	890M
General and Administrative Expenses	267M	304M	319M	279M	258M
Research And Development Expense From Footnotes	108M	115M	102M	99M	104M
Net Rental Expense, Total	7M	9M	10M	11M	13M
Imputed Operating Lease Interest Expense	1.36M	1.59M	1.59M	1.72M	1.62M
Imputed Operating Lease Depreciation	5.64M	7.41M	8.41M	9.28M	11.38M
Stock-Based Comp., Other (Total)	1.2M	666K	-	-	-
Total Stock-Based Compensation	1.2M	666K	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	1.79B	1.13B	403M	496M	615M
Short Term Investments	-	100M	-	-	-
Total Cash And Short Term Investments	1.79B	1.23B	403M	496M	615M
Accounts Receivable, Total	804M	1.16B	1.01B	785M	855M
Other Receivables	239M	315M	243M	239M	188M
Total Receivables	1.04B	1.47B	1.25B	1.02B	1.04B
Inventory	1.07B	1.63B	1.86B	1.36B	1.35B
Other Current Assets, Total	150M	48M	1.33B	29M	443M
Total Current Assets	4.06B	4.39B	4.85B	2.91B	3.45B
Gross Property Plant And Equipment	7.5B	8.28B	7.46B	7.67B	7.81B
Accumulated Depreciation	-5.34B	-5.7B	-5.14B	-5.39B	-5.67B
Net Property Plant And Equipment	2.16B	2.58B	2.32B	2.28B	2.14B
Long-term Investments	2M	56M	91M	859M	706M
Goodwill	808M	1.32B	1.84B	1.38B	1.3B
Other Intangibles, Total	711M	1.07B	1.39B	1.24B	1.13B
Accounts Receivable Long-Term	21M	34M	70M	77M	34M
Loans Receivable Long-Term	-	-	-	-	232M
Deferred Tax Assets Long-Term	326M	192M	54M	165M	167M
Other Long-Term Assets, Total	793M	872M	665M	746M	555M
Total Assets	8.88B	10.52B	11.28B	9.66B	9.71B
Liabilities
Accounts Payable, Total	681M	1.01B	709M	584M	648M
Accrued Expenses, Total	206M	343M	251M	175M	206M
Current Portion of Long-Term Debt	525M	628M	785M	22M	533M
Current Portion of Leases	41M	47M	45M	50M	51M
Current Income Taxes Payable	24M	25M	38M	42M	48M
Unearned Revenue Current, Total	18M	17M	10M	18M	20M
Other Current Liabilities	327M	311M	582M	283M	267M
Total Current Liabilities	1.82B	2.38B	2.42B	1.17B	1.77B
Long-Term Debt	2.18B	2.67B	3.27B	2.78B	2.29B
Long-Term Leases	85M	158M	147M	154M	139M
Unearned Revenue Non Current	34M	34M	27M	24M	22M
Pension & Other Post Retirement Benefits	1.2B	877M	367M	498M	429M
Deferred Tax Liability Non Current	113M	223M	284M	194M	168M
Other Non Current Liabilities	442M	414M	339M	330M	299M
Total Liabilities	5.88B	6.76B	6.85B	5.16B	5.12B
Common Stock, Total	87M	86M	86M	86M	86M
Retained Earnings	885M	267M	250M	443M	-177M
Comprehensive Income and Other	2.03B	3.4B	4.08B	3.97B	4.68B
Total Common Equity	3B	3.76B	4.42B	4.5B	4.59B
Minority Interest	-2M	6M	6M	6M	6M
Total Equity	3B	3.76B	4.43B	4.51B	4.59B
Total Liabilities And Equity	8.88B	10.52B	11.28B	9.66B	9.71B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	86.35M	86.35M	86.35M	86.35M	86.35M
ECS Total Common Shares Outstanding	86.35M	86.35M	86.35M	86.35M	86.35M
Book Value / Share	34.76	43.5	51.2	52.13	53.11
Tangible Book Value	1.48B	1.36B	1.18B	1.88B	2.16B
Tangible Book Value Per Share	17.16	15.73	13.72	21.73	24.99
Total Debt	2.83B	3.5B	4.25B	3.01B	3.01B
Net Debt	1.04B	2.27B	3.84B	2.51B	2.4B
Debt Equivalent of Unfunded Proj. Benefit Obligation	1.06B	717M	232M	361M	291M
Debt Equivalent Oper. Leases	56M	72M	80M	88M	104M
Minority Interest, Total (Incl. Fin. Div)	-2M	6M	6M	6M	6M
Equity Method Investments, Total	2M	56M	91M	859M	706M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	255M	421M	418M	279M	266M
Inventories - Work In Process, Total	815M	1.21B	1.44B	1.08B	1.08B
Inventories - Finished Goods, Total	-	-	-	-	-
Land - (BS)	1.26B	1.38B	1.21B	1.22B	1.21B
Machinery, Total	6B	6.53B	5.85B	6.01B	6.16B
Full Time Employees	12.97K	12.98K	13.19K	10.98K	12.34K
Part Time Employees	1.79K	1.88K	1.98K	1.87K	-
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	10M	10M	14M	12M	12M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	885M	267M	250M	443M	-177M
Depreciation & Amortization - CF	371M	390M	380M	394M	398M
Amortization of Goodwill and Intangible Assets - (CF)	89M	112M	156M	168M	162M
Depreciation & Amortization, Total	460M	502M	536M	562M	560M
(Gain) Loss From Sale Of Asset	-1M	-1M	3M	-2M	-1M
Asset Writedown & Restructuring Costs	44M	11M	10M	434M	6M
(Income) Loss On Equity Investments - (CF)	-	-	-3M	172M	133M
Net Cash From Discontinued Operations	-9M	-32M	-28M	-14M	-
Other Operating Activities, Total	-866M	56M	22M	-1.35B	-51M
Change In Accounts Receivable	-8M	-213M	62M	230M	-54M
Change In Inventories	73M	-441M	-403M	465M	-19M
Change In Accounts Payable	41M	241M	-130M	-118M	73M
Change in Other Net Operating Assets	-34M	17M	-160M	17M	38M
Cash from Operations	585M	407M	159M	838M	508M
Capital Expenditure	-456M	-479M	-407M	-326M	-320M
Sale of Property, Plant, and Equipment	4M	3M	5M	3M	2M
Cash Acquisitions	-25M	-1.01B	-1.12B	-	-
Divestitures	821M	115M	8M	1.19B	-
Investment in Marketable and Equity Securities, Total	-749M	928M	510M	-465M	43M
Other Investing Activities, Total	52M	7M	-43M	17M	12M
Cash from Investing	-353M	-432M	-1.05B	423M	-263M
Long-Term Debt Issued, Total	1B	1.1B	1.38B	383M	20M
Total Debt Issued	1B	1.1B	1.38B	383M	20M
Long-Term Debt Repaid, Total	-1.05B	-564M	-689M	-1.69B	-66M
Total Debt Repaid	-1.05B	-564M	-689M	-1.69B	-66M
Repurchase of Common Stock	-37M	-	-	-	-
Common Dividends Paid	-82M	-86M	-91M	-91M	-9M
Common & Preferred Stock Dividends Paid	-82M	-86M	-91M	-91M	-9M
Other Financing Activities, Total	-80M	-63M	14M	-72M	-42M
Cash from Financing	-247M	389M	613M	-1.47B	-97M
Foreign Exchange Rate Adjustments	-10M	8M	-4M	-9M	5M
Net Change in Cash	-25M	372M	-283M	-214M	153M
Supplemental Items
Cash Interest Paid	79M	63M	65M	71M	42M
Cash Income Tax Paid (Refund)	215M	10M	-4M	53M	47M
Levered Free Cash Flow	330M	-158M	-1.09B	1.68B	-109M
Unlevered Free Cash Flow	371M	-117M	-1.04B	1.73B	-79.62M
Change In Net Working Capital	-131M	444M	1.4B	-1.54B	334M
Net Debt Issued / Repaid	-48M	538M	690M	-1.3B	-46M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	2.67	3.13	2.16	-0.48	0.15
Return on Total Capital	4.15	4.64	2.96	-0.63	0.19
Return On Equity %	32.2	6.48	4.52	-18.85	-3.87
Return on Common Equity	31.46	6.48	4.5	-18.9	-3.9
Margin Analysis
Gross Profit Margin %	25.52	24.41	23.95	18.89	20.39
SG&A Margin	17.38	16.77	17.28	18.44	18.49
EBITDA Margin %	12.84	12.36	10.57	6.26	8.18
EBITA Margin %	7.62	7.91	6.59	1.3	2.91
EBIT Margin %	6.16	6.43	4.66	-1.21	0.36
Income From Continuing Operations Margin %	14.89	2.9	2.29	-12.54	-2.76
Net Income Margin %	14.5	3.53	3.09	6.6	-2.78
Net Avail. For Common Margin %	14.61	2.9	2.27	-12.56	-2.78
Normalized Net Income Margin	12.19	3.73	2.84	-3.12	-1.16
Levered Free Cash Flow Margin	5.41	-2.1	-13.44	25.05	-1.71
Unlevered Free Cash Flow Margin	6.08	-1.54	-12.86	25.7	-1.25
Asset Turnover
Asset Turnover	0.69	0.78	0.74	0.64	0.66
Fixed Assets Turnover	2.77	3.19	3.3	2.92	2.88
Receivables Turnover (Average Receivables)	7.4	7.7	7.46	7.48	7.76
Inventory Turnover (Average Inventory)	4.01	4.23	3.52	3.38	3.74
Short Term Liquidity
Current Ratio	2.23	1.84	2	2.48	1.95
Quick Ratio	1.56	1.14	0.68	1.29	0.94
Operating Cash Flow to Current Liabilities	0.32	0.17	0.07	0.71	0.29
Days Sales Outstanding (Average Receivables)	49.44	47.41	48.94	48.82	47.14
Days Outstanding Inventory (Average Inventory)	91.18	86.36	103.67	107.94	97.78
Average Days Payable Outstanding	55.34	49.12	49.12	47.72	44.59
Cash Conversion Cycle (Average Days)	85.27	84.65	103.49	109.04	100.34
Long Term Solvency
Total Debt/Equity	94.4	93.14	95.93	66.78	65.59
Total Debt / Total Capital	48.56	48.22	48.96	40.04	39.61
LT Debt/Equity	75.53	75.2	77.19	65.19	52.87
Long-Term Debt / Total Capital	38.85	38.93	39.39	39.08	31.93
Total Liabilities / Total Assets	66.23	64.23	60.76	53.37	52.71
EBIT / Interest Expense	5.7	7.25	5.03	-1.16	0.49
EBITDA / Interest Expense	12.67	14.75	12.17	6.87	12.4
(EBITDA - Capex) / Interest Expense	5.76	7.6	6.75	2.21	5.6
Total Debt / EBITDA	3.39	3.55	4.65	6.26	5.17
Net Debt / EBITDA	1.24	2.3	4.21	5.23	4.11
Total Debt / (EBITDA - Capex)	7.45	6.88	8.39	19.42	11.45
Net Debt / (EBITDA - Capex)	2.73	4.46	7.6	16.22	9.11
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-10.26	23.8	32.57	-16.99	-5.18
Gross Profit, 1 Yr. Growth %	-11.58	18.57	27.02	-34.54	2.37
EBITDA, 1 Yr. Growth %	-17.04	17.93	15.54	-50.7	24.05
EBITA, 1 Yr. Growth %	-24.64	27.51	17.14	-83.58	112.64
EBIT, 1 Yr. Growth %	-29.06	27.89	9.28	-121.66	-128.4
Earnings From Cont. Operations, 1 Yr. Growth %	277.18	-75.91	59.48	-555.14	-79.1
Net Income, 1 Yr. Growth %	331.71	-69.83	-6.37	77.2	-139.95
Normalized Net Income, 1 Yr. Growth %	128.82	-62.09	17.76	-192.1	-64.66
Diluted EPS Before Extra, 1 Yr. Growth %	256.86	-75.38	58.62	-558.15	-79
Accounts Receivable, 1 Yr. Growth %	-4.85	44.15	-12.86	-22.35	8.92
Inventory, 1 Yr. Growth %	-10.46	52.62	13.96	-26.92	-0.88
Net Property, Plant and Equip., 1 Yr. Growth %	-3.44	19.2	-10.3	-1.38	-6.3
Total Assets, 1 Yr. Growth %	2.13	18.45	7.15	-14.37	0.48
Tangible Book Value, 1 Yr. Growth %	48.94	-8.37	-12.42	58.98	15.03
Common Equity, 1 Yr. Growth %	12.44	25.16	17.7	1.81	1.89
Cash From Operations, 1 Yr. Growth %	-9.02	-30.43	-60.93	427.04	-39.38
Capital Expenditures, 1 Yr. Growth %	-10.24	5.04	-4.01	-19.9	-1.84
Levered Free Cash Flow, 1 Yr. Growth %	65.61	-147.54	341.3	-255.11	-106.48
Unlevered Free Cash Flow, 1 Yr. Growth %	50.45	-130.87	404.12	-266.34	-104.61
Dividend Per Share, 1 Yr. Growth %	5.26	5	0	-90.48	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-5.42	5.4	15.11	4.9	-11.28
Gross Profit, 2 Yr. CAGR %	-5.46	2.33	11.57	-8.81	-18.14
EBITDA, 2 Yr. CAGR %	-9.44	-0.58	3.9	-24.66	-21.8
EBITA, 2 Yr. CAGR %	-14.63	-1.55	6.6	-56.27	-40.92
EBIT, 2 Yr. CAGR %	-17.69	-4.24	-0.4	-51.55	-75.2
Earnings From Cont. Operations, 2 Yr. CAGR %	79.54	-4.67	-54.89	169.42	-2.46
Net Income, 2 Yr. CAGR %	43.3	14.12	-46.85	28.81	-15.86
Normalized Net Income, 2 Yr. CAGR %	90.6	-6.91	-44.43	3.71	-42.95
Diluted EPS Before Extra, 2 Yr. CAGR %	122.76	-6.27	-54.52	169.58	-1.92
Accounts Receivable, 2 Yr. CAGR %	-7.86	17.12	12.08	-17.7	-8.04
Inventory, 2 Yr. CAGR %	-10.87	16.9	31.88	-8.74	-14.89
Net Property, Plant and Equip., 2 Yr. CAGR %	0.75	7.28	3.5	-5.95	-3.87
Total Assets, 2 Yr. CAGR %	1.1	9.98	12.71	-4.19	-7.24
Tangible Book Value, 2 Yr. CAGR %	16.6	16.83	-10.58	17.75	35.23
Common Equity, 2 Yr. CAGR %	3.9	18.63	21.37	9.47	1.85
Cash From Operations, 2 Yr. CAGR %	-0.09	-20.44	-47.87	43.49	78.74
Capital Expenditures, 2 Yr. CAGR %	-2.73	-2.9	-5.53	-12.31	-11.33
Levered Free Cash Flow, 2 Yr. CAGR %	-29.29	-10.82	80.61	161.26	-68.29
Unlevered Free Cash Flow, 2 Yr. CAGR %	-27.53	-31.26	65.97	189.14	-72.29
Dividend Per Share, 2 Yr. CAGR %	5.41	5.13	2.47	-69.14	-69.14
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-2.22	3.46	5.94	3.23	1.43
Gross Profit, 3 Yr. CAGR %	-3.5	1.91	3.21	-6.6	-5.23
EBITDA, 3 Yr. CAGR %	-4.5	-0.77	-3.28	-19.06	-11.04
EBITA, 3 Yr. CAGR %	-8.09	-2.14	-4.76	-42.97	-25.92
EBIT, 3 Yr. CAGR %	-11.2	-4.33	-10.73	-40.26	-59.45
Earnings From Cont. Operations, 3 Yr. CAGR %	147.44	-8.08	-8.44	-2.52	14.91
Net Income, 3 Yr. CAGR %	116.67	-14.75	6.84	-20.6	-12.81
Normalized Net Income, 3 Yr. CAGR %	41.33	11.22	-10.96	-34.42	-27.56
Diluted EPS Before Extra, 3 Yr. CAGR %	244.8	6.9	-9.62	-1.77	15.13
Accounts Receivable, 3 Yr. CAGR %	-15.15	6.97	6.13	-0.79	-9.64
Inventory, 3 Yr. CAGR %	-13.96	6.63	15.91	8.32	-6.19
Net Property, Plant and Equip., 3 Yr. CAGR %	-15.4	6.56	1.13	1.85	-6.07
Total Assets, 3 Yr. CAGR %	-5.16	6.58	9.07	2.86	-2.66
Tangible Book Value, 3 Yr. CAGR %	38.99	7.6	6	8.18	16.84
Common Equity, 3 Yr. CAGR %	9.48	10.55	18.32	14.47	6.88
Cash From Operations, 3 Yr. CAGR %	-12.32	-11.44	-37.23	12.73	7.67
Capital Expenditures, 3 Yr. CAGR %	4.73	-0.21	-7.12	-10.58	-8.95
Levered Free Cash Flow, 3 Yr. CAGR %	-44.62	-37.85	76.06	71.51	-23.8
Unlevered Free Cash Flow, 3 Yr. CAGR %	-42.97	-45.16	61.56	65.93	-27.2
Dividend Per Share, 3 Yr. CAGR %	7.72	5.27	3.39	-53.58	-54.33
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-5.03	-0.37	4.37	-0.32	-1.32
Gross Profit, 5 Yr. CAGR %	-2.43	0.91	2.24	-6.17	-5.93
EBITDA, 5 Yr. CAGR %	-1.65	-0.59	-1.02	-15.17	-11.23
EBITA, 5 Yr. CAGR %	1.39	2.72	-2.31	-32.87	-21.41
EBIT, 5 Yr. CAGR %	-1.38	-0.16	-6.83	-31.95	-46.61
Earnings From Cont. Operations, 5 Yr. CAGR %	40.34	2.35	25.26	24.46	-6.09
Net Income, 5 Yr. CAGR %	39.92	6.82	23.5	0.55	-2.89
Normalized Net Income, 5 Yr. CAGR %	31.07	2.83	-2.72	0.47	-25.6
Diluted EPS Before Extra, 5 Yr. CAGR %	41.71	3.87	53.35	36.29	-6.62
Accounts Receivable, 5 Yr. CAGR %	-3.4	1.27	-5.16	-3.68	0.24
Inventory, 5 Yr. CAGR %	-4.53	2.7	2.07	0.19	2.44
Net Property, Plant and Equip., 5 Yr. CAGR %	-7.18	-3.91	-8.3	1.41	-0.9
Total Assets, 5 Yr. CAGR %	4.23	1.27	1.62	2.16	2.23
Tangible Book Value, 5 Yr. CAGR %	-6.25	-8.3	16.51	11.47	16.75
Common Equity, 5 Yr. CAGR %	5.37	8.04	14.09	10.12	11.43
Cash From Operations, 5 Yr. CAGR %	-3.3	-9.99	-28.78	7.42	-4.6
Capital Expenditures, 5 Yr. CAGR %	0.99	1.76	0.5	-7.52	-8.83
Levered Free Cash Flow, 5 Yr. CAGR %	-0.61	-38.93	-10.96	20.57	-11.36
Unlevered Free Cash Flow, 5 Yr. CAGR %	-1.03	-42.25	-12.27	19.54	-20.24
Dividend Per Share, 5 Yr. CAGR %	10.76	8.45	5.59	-35.56	-36.25